Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

TFH CELL DIFFERENTIATION

Is it dead or alive? TLR8 can tell

Nature Immunology volume 19, pages 324–326 (2018)Cite this article

The sensing of viable pathogens by the receptor TLR8 on human monocytes provides key signals that initiate the differentiation of naive CD4+ T cells into follicular helper T cells. Targeting TLR8 might represent a novel approach for improving immunity following vaccination.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: TLR8-medited induction of IL-12 drives a TFH cell program in naive human CD4+ T cells.

References

  1. Amanna, I. J. & Slifka, M. K. Antiviral Res. 84, 119–130 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Slifka, M. K. & Amanna, I. Vaccine 32, 2948–2957 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. De Gregorio, E. & Rappuoli, R. Nat. Rev. Immunol. 14, 505–514 (2014).

    Article  PubMed  Google Scholar 

  4. Ugolini, M. Nat. Immunol. https://doi.org/10.1038/s41590-018-0068-4 (2018).

    PubMed  Google Scholar 

  5. Crotty, S. Immunity 41, 529–542 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tangye, S. G., Ma, C. S., Brink, R. & Deenick, E. K. Nat. Rev. Immunol. 13, 412–426 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Ma, C. S. et al. Blood 119, 3997–4008 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Schmitt, N. et al. Immunity 31, 158–169 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ma, C. S. et al. J. Exp. Med. 213, 1589–1608 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hartmann, G. Adv. Immunol. 133, 121–169 (2017).

    Article  CAS  PubMed  Google Scholar 

  11. Oh, D. Y. et al. J. Infect. Dis. 198, 701–709 (2008).

    Article  CAS  PubMed  Google Scholar 

  12. Picard, C., Casanova, J. L. & Puel, A. Clin. Microbiol. Rev. 24, 490–497 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Schmitt, N. et al. Blood 121, 3375–3385 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

    Stuart G. Tangye

  2. St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia

    Stuart G. Tangye

Authors
  1. Stuart G. Tangye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart G. Tangye.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tangye, S.G. Is it dead or alive? TLR8 can tell. Nat Immunol 19, 324–326 (2018). https://doi.org/10.1038/s41590-018-0070-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-018-0070-x

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing